Aptevo Therapeutics Inc.

APVO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.84

$0 (0.00%)

At close: Sep 21, 2026, 3:59 PM ET

$1.81

-$0.03 (-1.63%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $4.02M

Enterprise Value $-1.56M

Beta 1.61

Average Volume 84.31K

Shares Outstanding (Diluted) 1.2M

Shares Change YoY 2817.39%

Institutional Ownership 5.07%

Exchange NASDAQ

ISIN US03835L7029

Price Performance

Price Change 1M -33.3%

Price Change 3M -60.3%

Price Change 6M -58.5%

Price Change YTD -80.4%

Price Change 1Y -94.0%

Price Change 3Y -100.0%

Price Change 5Y -100.0%

1M CAGR (ann.) -54.8%

1Y CAGR (ann.) -92.8%

5Y CAGR (ann.) -95.5%

All-Time CAGR -81.9%

Valuation

PE Ratio -0.01

Forward PE N/A

PEG Ratio -0.00

Forward PEG 0.00

PS Ratio N/A

Forward PS 0.60

PB Ratio 0.67

P/FCF Ratio -0.16

P/Adj. FCF Ratio -0.16

P/OCF Ratio -0.09

EV/Sales N/A

EV/EBIT 0.06

EV/EBITDA 0.06

EV/FCF 0.06

Earnings Yield -11477.2%

FCF Yield -629.8%

Adj. FCF Yield -634.6%

Financial Health

Net Cash $5.59M

Total Debt $4.21M

Cash & Short-Term Investments $9.8M

Total Assets $14.52M

Current Ratio 2.08

Quick Ratio 2.08

Debt / Equity Ratio 0.70

Debt / EBITDA -0.16

Debt / FCF -0.17

OCF / Debt -6.02

Interest Coverage 0.00

Altman Z-Score -33.09

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -0.8%

Returns

Return on Assets -181.9%

Return on Equity -201.5%

Return on Invested Capital -262.3%

Return on Capital Employed -288.1%

Return on Tangible Assets -181.9%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y -100.0%

Revenue CAGR 10Y -32.9%

EPS CAGR 3Y 147.6%

EPS CAGR 5Y 7.4%

EPS CAGR 10Y 24.2%

FCF CAGR 3Y -2.1%

FCF CAGR 5Y -13.0%

FCF CAGR 10Y 8.9%

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y 33.0%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$3.71

EPS Growth Est (next Q) -90.7%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Cash Flow

Operating Cash Flow $-25.34M

Free Cash Flow $-25.34M

Adj. Free Cash Flow $-25.54M

FCF Per Share -$21.18

OCF Per Share -$21.18

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-116K

Operating Income $-26.89M

EBITDA $-26.42M

Net Income $-26.41M

EPS (Diluted) -$211.18

Revenue / Employee N/A

Profit / Employee $-800.24K

Employees 33